Why "Trading One Addiction for Another" Gets the Science Wrong

The short answer, and why the question misfires

No. Treating opioid use disorder with buprenorphine or methadone is not substituting one addiction for another. At a therapeutic, stable dose these medications occupy the same receptors that opioids act on, but they do not produce a high — they reduce cravings and withdrawal so a person can hold a job, care for a family, and rebuild a life 1Ref 1National Institute on Drug Abuse (2024).Medications for Opioid Use Disorder.Treating opioid use disorder with methadone or buprenorphine is not 'substituting one addiction for another'; at therapeutic doses the medications reduce cravings and withdrawal without producing a high.. That is close to the opposite of what addiction does.

The question misfires because it treats any daily reliance on a substance as identical to addiction. It is not. A person on medication is stable, functioning, and safer; a person in active addiction is losing control and at risk of dying. Calling those two states the same thing keeps people away from the treatment most likely to keep them alive.

There is a reason this particular myth is worth taking apart carefully rather than waving off. It is not a fringe belief; it is common, it is often spoken by people who mean well — family members, sponsors, even some clinicians — and it carries real weight because it sounds like plain common sense. Untangling it takes a little pharmacology and a clear look at what the words actually mean, which is what the rest of this page does.

Dependence is not the same as addiction

The whole confusion collapses once two words are separated. Physical dependence is the body's normal adaptation to a substance taken regularly: stop it suddenly and withdrawal follows. It happens with many ordinary medicines — it can develop even when a benzodiazepine is taken exactly as prescribed 2Ref 2U.S. Food and Drug Administration (2020).Benzodiazepine Drug Class: Drug Safety Communication — Boxed Warning Updated to Improve Safe Use.Physical dependence can develop even when a medication is taken exactly as prescribed — used to show that dependence is a normal physiological adaptation distinct from addiction.. Addiction is different: compulsive use that continues despite harm, with loss of control over the drug.

You can be dependent without being addicted, and this is the crux of dependence vs addiction. Someone stabilized on buprenorphine is physically dependent on it — stopping abruptly would bring withdrawal — but they are not compulsively seeking it, not using it to get high, and not damaging their life to get more. Dependence is a physiological fact; addiction is a disease of behavior and brain circuitry. Effective medication turns the second into, at most, the first.

The two words describe genuinely different things:

What the medication actually does in the brain

Understanding the pharmacology dissolves the rest of the myth. Buprenorphine is a partial agonist: it activates opioid receptors enough to prevent withdrawal and cravings but has a ceiling, so past a certain point more medication does not produce more effect or a high. Methadone is a full agonist given at a steady, controlled dose that keeps receptors occupied without the peaks and crashes of illicit use 1Ref 1National Institute on Drug Abuse (2024).Medications for Opioid Use Disorder.Treating opioid use disorder with methadone or buprenorphine is not 'substituting one addiction for another'; at therapeutic doses the medications reduce cravings and withdrawal without producing a high..

The ceiling effect on buprenorphine is worth dwelling on, because it is the clearest answer to "isn't it just another opioid?" Past a certain dose, taking more does not produce more effect — a built-in limit that ordinary opioids of misuse do not have. That property is part of why buprenorphine is safer in overdose terms than the drugs it replaces, and part of why a stable dose produces steadiness rather than a high 1Ref 1National Institute on Drug Abuse (2024).Medications for Opioid Use Disorder.Treating opioid use disorder with methadone or buprenorphine is not 'substituting one addiction for another'; at therapeutic doses the medications reduce cravings and withdrawal without producing a high..

The practical result is a flat, stable state rather than the roller coaster of active addiction. Cravings quiet down. The frantic daily search for the next dose ends. The brain circuits that drive compulsive use get room to settle. This is why people on a stable dose describe feeling normal, not high — and why medication-assisted treatment is understood as restoring function rather than feeding a habit.

The diabetes-and-insulin comparison

A common way to explain this is the comparison to insulin. A person with diabetes takes insulin daily, is physiologically dependent on it, and would become dangerously ill without it — yet no one calls that an addiction, because the medicine restores health rather than harming it. Medication for opioid use disorder follows the same logic: a daily medicine that manages a chronic condition and keeps a person well.

People sometimes push back that the insulin comparison lets addiction "off the hook" by calling it a disease. It does not. Calling something a chronic medical condition is not an excuse; it is a description of how it behaves and how it responds to treatment. Diabetes, asthma, and high blood pressure are all chronic conditions shaped by biology and behavior together and managed over the long term. Opioid use disorder fits that same pattern, and treating it that way is what the evidence supports.

The analogy is not perfect, and it is worth being honest about that. But it holds where it matters most — including the danger of stopping. Just as abruptly stopping insulin is hazardous, forced or unsupported abstinence from opioids is dangerous, because tolerance drops and a return to use can be fatal. Studies of people leaving incarceration, where abstinence is imposed, find sharply elevated overdose death in the weeks after release 3Ref 3Binswanger IA, Nowels C, Corsi KF, et al. (2012).Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors.Overdose risk is sharply elevated in the weeks after release from incarceration, driven partly by lowered tolerance during enforced abstinence — evidence that forced abstinence without medication raises overdose risk.. Medication protects against exactly that.

Is it "real" treatment? What the trials show

By the standards used for any medicine, yes. Controlled trials show buprenorphine keeps people in treatment far better than placebo at adequate doses — and retention is the thing most tied to recovery — which is the signature of an effective medication, not a habit 4Ref 4Mattick RP, Breen C, Kimber J, Davoli M (2014).Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.Buprenorphine retains patients in treatment better than placebo at adequate doses — evidence that it is an effective medication rather than a substitute habit.. Methadone has a similarly deep evidence base for holding people in care and suppressing illicit opioid use.

And the outcome that matters most is survival. Pooled analyses across many studies find that all-cause and overdose death rates are substantially lower while people stay on methadone or buprenorphine than when they are off them 5Ref 5Sordo L, Barrio G, Bravo MJ, et al. (2017).Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.All-cause and overdose mortality are substantially lower while people are retained on methadone or buprenorphine than when they are out of treatment.. Staying on medication is associated with markedly lower death rates than being out of treatment 5Ref 5Sordo L, Barrio G, Bravo MJ, et al. (2017).Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.All-cause and overdose mortality are substantially lower while people are retained on methadone or buprenorphine than when they are out of treatment.. A treatment that keeps people alive is not a substitute addiction; it is medicine doing its job.

Skeptics sometimes ask why, if the medication works, people ever stop it and struggle again. The answer usually is not that the medication failed but that it was stopped — often under pressure from the very belief this page is about. When people leave treatment, whether by choice, by a program's time limit, or because someone convinced them that being on medication was not "real" recovery, the risk of a return to use and overdose climbs. The evidence points toward staying on the medication as long as it helps, not toward proving a point by stopping 5Ref 5Sordo L, Barrio G, Bravo MJ, et al. (2017).Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.All-cause and overdose mortality are substantially lower while people are retained on methadone or buprenorphine than when they are out of treatment..

Where the myth comes from, and what it costs

The idea has deep roots — in a moral view of addiction as a failure of willpower, in some abstinence-only traditions that count any medication as cheating, and in the visible fact that these are regulated opioids dispensed inside a clinical framework. Methadone, for instance, is provided only through federally regulated programs, which can make it look more like a controlled substance than a prescription. Buprenorphine and naltrexone round out three established, federally recognized medications for opioid use disorder 6Ref 6Substance Abuse and Mental Health Services Administration (2021).TIP 63: Medications for Opioid Use Disorder — Full Document.Methadone, buprenorphine, and naltrexone are the three FDA-approved, federally recognized medications for opioid use disorder — framing them as established medical treatment..

The cost of the myth is measured in lives. When shame or misinformation keeps someone off effective medication — or pressures them to quit it too soon — the risk is not a lesser recovery but a return to use and an overdose. The most dangerous thing about "trading one addiction for another" is that believing it can be fatal.

It is not only individuals who pay. When the belief takes hold in a family, a courtroom, a jail, or a treatment program, it can harden into rules that push people off effective medication — and those settings are exactly where the danger of a forced return to use is highest 3Ref 3Binswanger IA, Nowels C, Corsi KF, et al. (2012).Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors.Overdose risk is sharply elevated in the weeks after release from incarceration, driven partly by lowered tolerance during enforced abstinence — evidence that forced abstinence without medication raises overdose risk.. A myth held by a system does more harm than a myth held by one person, because it removes the medication from people who have the least power to insist on it.

When someone says it to you

If someone you love is about to refuse or quit medication because of this idea, arguing pharmacology rarely lands in the moment. What tends to help more is a few plain distinctions: depending on a medicine is not the same as being addicted to a drug; feeling normal is the goal, not a loophole; and the safest place to be, by the data, is on the medication rather than off it 5Ref 5Sordo L, Barrio G, Bravo MJ, et al. (2017).Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.All-cause and overdose mortality are substantially lower while people are retained on methadone or buprenorphine than when they are out of treatment.. You do not have to win a debate — you only have to help keep a door open.

It can also help to name what the belief is quietly doing. The phrase often masks a fear that recovery on medication is somehow less earned. But recovery is measured by a life reclaimed, not by whether it is chemical-free. A person back at work, present with their kids, and out of danger is not halfway recovered because a prescription is part of the picture. That is what recovery looks like, and it is worth defending against a slogan.

If you or someone you love is weighing this

If this myth is the thing standing between someone and treatment, the useful next move is practical, not philosophical. Finding a suboxone prescriber is often easier than people expect, through office-based clinicians and telehealth, and starting medication is the step most tied to staying alive. For families, the same distinction between dependence and addiction can reframe the line between helping and enabling — supporting a loved one's medication is not enabling their addiction.

It also helps to have naloxone on hand regardless of where someone is in treatment, since a return to use is most dangerous after any break. Getting naloxone, and how it works to reverse an opioid overdose, is covered on its own page. The medicine that treats the condition and the medicine that reverses an overdose are both worth having; neither is an admission of failure.

None of this is a decision anyone has to make alone. A prescriber can explain the options, a pharmacist can answer questions, and support exists for families trying to make sense of it. The one thing worth resisting is the pressure — internal or external — to treat effective medication as a failure and stop it before it has done its work.